Enfusion Inc
NYSE:ENFN
Enfusion Inc
Cash & Cash Equivalents
Enfusion Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Enfusion Inc
NYSE:ENFN
|
Cash & Cash Equivalents
$35.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Salesforce Inc
NYSE:CRM
|
Cash & Cash Equivalents
$8.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
26%
|
CAGR 10-Years
27%
|
|
Synopsys Inc
NASDAQ:SNPS
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
2%
|
|
Intuit Inc
NASDAQ:INTU
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
Adobe Inc
NASDAQ:ADBE
|
Cash & Cash Equivalents
$6.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
24%
|
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
Cash & Cash Equivalents
$1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
See Also
What is Enfusion Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.6m
USD
Based on the financial report for Dec 31, 2023, Enfusion Inc's Cash & Cash Equivalents amounts to 35.6m USD.
What is Enfusion Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
37%
Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Enfusion Inc have been 37% over the past three years .